Literature DB >> 36104594

The value of injectable viscoelastic supplements for joints.

Dermot J Bowden1, Stephen J Eustace2, Eoin C Kavanagh2.   

Abstract

Intra-articular viscoelastic supplements are commonly administered by musculoskeletal radiologists for the treatment of symptomatic osteoarthritis (OA). This article provides an overview of the putative mechanism of action of the agents, a brief review of the evidence base underlying the practice, a commentary on some of the major society guidelines regarding the treatment, and a description of the adverse events that are associated with intra-articular hyaluronic acid administration.
© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Entities:  

Keywords:  Hyaluronate; Hyaluronic acid; Intra-articular joint injection; Osteoarthritis; Viscoelastic supplements; Viscosupplementation

Year:  2022        PMID: 36104594     DOI: 10.1007/s00256-022-04178-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.128


  5 in total

1.  Corticosteroid injections for osteoarthritis of the knee: meta-analysis.

Authors:  Bruce Arroll; Felicity Goodyear-Smith
Journal:  BMJ       Date:  2004-03-23

2.  The local effects of compound F (hydrocortisone) injected into joints.

Authors:  J L HOLLANDER
Journal:  Bull Rheum Dis       Date:  1951-10

3.  Synovial fluid as a lubricant.

Authors:  D V Davies
Journal:  Fed Proc       Date:  1966 May-Jun

4.  The Impact of Excluding Patients with End-Stage Knee Disease in Intra-Articular Hyaluronic Acid Trials: A Systematic Review and Meta-Analysis.

Authors:  Mathew Nicholls; Peter Shaw; Faizan Niazi; Mohit Bhandari; Asheesh Bedi
Journal:  Adv Ther       Date:  2018-12-01       Impact factor: 3.845

Review 5.  The efficacy of multiple versus single hyaluronic acid injections: a systematic review and meta-analysis.

Authors:  Andrew Concoff; Parag Sancheti; Faizan Niazi; Peter Shaw; Jeffrey Rosen
Journal:  BMC Musculoskelet Disord       Date:  2017-12-21       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.